F.D.A. Expands Access to Clozapine, a Key Treatment for Schizophrenia
Federal regulators will no longer require patients to provide blood tests before receiving the drug from pharmacies.
November 7, 2026
Federal regulators will no longer require patients to provide blood tests before receiving the drug from pharmacies.